GLOBAL HEALTH | GLOBAL PARTNERSHIPS | GLOBAL IMPACT

Research

Photo for EpiDream Genetics

EpiDream Genetics

Official Title

EpiDREAM – A prospective cohort to determine environment and genetic determinants of metabolic syndrome related factors.

Status

Completed

Study Design

Cohort study

Primary Endpoint

Diabetes and CVD

Number of Patients

15466

Number of Sites

191

Number of Countries

21

Study Period

2008–2010

Principal Investigator

Sonia Anand

Program Manager

Jackie Bosch

Research Coordinator

Dipika Desai

Collaborators

GSK, Sanofi Aventis

Key Publications

  • Anand SS1, Meyre D, Pare G, Bailey SD, Xie C, Zhang X, Montpetit A, Desai D, Bosch J, Mohan V, Diaz R, McQueen MJ, Cordell HJ, Keavney B, Yusuf S, Gaudet D, Gerstein H, Engert JC; EpiDREAM Genetics Investigators. Genetic information and the prediction of incident type 2 diabetes in a high-risk multiethnic population: the EpiDREAM genetic study. Diabetes Care. 2013 Sep;36(9):2836-42. doi: 10.2337/dc12-2553. Epub 2013 Apr 19.